Stay updated on Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.

Latest updates to the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s footer revision/version has been updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check34 days agoChange DetectedAdded related topics: Lung cancer and MedlinePlus Genetics.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.5.0 added; Lung cancer and related topics (MedlinePlus Genetics) removed; Revision: v3.4.3 removed.SummaryDifference0.2%

- Check63 days agoChange DetectedLung cancer and MedlinePlus Genetics were added as related topics on the study page.SummaryDifference0.1%

- Check70 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision: v3.4.2 added. Lung cancer and related topics (MedlinePlus Genetics) and Revision: v3.4.1 were removed.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.